Clinical Trial

Survival, Quality of Life and Resectability in Locally Advanced Pancreatic Cancer

Study acronym: SQUARE
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 30, 2022 (before its estimated May 2025 completion). Its status may not reflect the trial's current state.
Summary
This study aims to assess overall survival, quality of life and resection rates in locally advanced pancreatic cancer
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2022-04-26.
Status change: Not Yet Recruiting → Recruiting 2022-11-23
Trial Details
NCT Number NCT05356039
Lead Sponsor Umeå University
Collaborators: University Hospital, Linkoeping, Lund University Hospital, Sahlgrenska University Hospital, Karolinska University Hospital, University Hospital, Umeå
Conditions Pancreas Cancer, Pancreas Neoplasm, Pancreas Disease, Pancreas Adenocarcinoma, Surgery, Chemotherapy Effect, Quality of Life, Locally Advanced Pancreatic Adenocarcinoma +1 more
Enrollment 300 participants
Start Date 2022-04-19
Primary Completion 2025-05 (estimated)
Study Completion 2028-05 (estimated)
Updated on ClinicalTrials.gov 2022-11-30